Thermo Fisher Scientific management check
TMO · Health Care · Life Sciences Tools & Services · CEO Marc N Casper
Filings as of
Closest peers in Life Sciences Tools & Services
- 101WATWaters Corporation76
- 108MTDMettler Toledo76
- 151DHRDanaher Corporation72
- 168IQVIQVIA71
- 307TMOThermo Fisher Scientific61
- 375CRLCharles River Laboratories56
- 386AAgilent Technologies55
- 443ILMNIllumina, Inc.47
- 453TECHBio-Techne45
The seven checks
- WatchTrailed its chosen peers
Have owners done well?
What $100 became since fiscal 2021
2633rdDetail
$100 invested at the start of fiscal 2021 grew to $126, against $157 for the peer group the company picked itself.
- GoodPay rose and fell with returns
Does pay follow performance?
Pay actually paid $100 value, each on its own scale
7740thDetail
Over 5 years, the CEO's pay actually paid (equity valued at the share price) had a correlation of 0.54 with shareholder return. 1 means pay moved in step; below 0, the opposite way.
- Watch1.2% of net income
What does the CEO cost owners?
$79.9m pay · $6.7bn net income, FY2025
4445thDetail
$79.9m of reported pay in fiscal 2025, against $6.7bn of net income.
- FlagCEO stake ≈ 1.0 years of pay
Do they own the stock?
123,200.592 shares ≈ $76.7m
6 mo: ▲ $0 bought · ▼ $66.5m sold
1413thDetail
The CEO holds 123,200.592 shares, directly or through trusts (unvested awards not counted): about 1.0 years of pay. 5 insiders sold $66.5m in the last six months and none bought. 92 of 96 sales ran on pre-arranged 10b5-1 plans.
- GoodShare count shrinking
Are owners being diluted?
Diluted shares −1.3% a year; flagged above +2%
Stock pay 0.7% of revenue
6657thDetail
Diluted shares changed -1.3% a year over the last three fiscal years. Stock-based pay was 0.7% of revenue in the latest year.
- Good5 leadership filings in 3 years
Is leadership stable?
5 filings under 8-K 5.02 in 3 years
CEO: Mr. Casper
100100thDetail
CEO in the pay table: Mr. Casper. 5 filings under 8-K item 5.02 (officers or directors leaving or joining, or new pay arrangements) in the last 3 years.
- GoodNo red flags on file
Are the books clean?
Since 2021
- 0Restated
- 0Auditor changes
- 0Late filings
- 010-K amended
100100thDetail
No restatements, auditor changes or late filings since 2021.
Reading the scores
Each check scored 0–100 from its own figure. The tick is the Health Care median; the ordinal is the share of ranked S&P 500 companies it matches or beats.
Hover a chart for its figures. Detail has the full reading.
Pay versus performance
From the proxy statement filed April 7, 2026.
Pay tied most to Adjusted EPS
Other key measuresOrganic Revenue GrowthAdjusted Net IncomeFree Cash FlowTotal Shareholder Return
Show the figures
| Fiscal year | CEO | CEO pay | Actually paid | Other executives (avg) | $100 became | Peers | Net income |
|---|---|---|---|---|---|---|---|
| 2025 | Mr. Casper | $79.9m | $116.1m | $7.6m | $126 | $157 | $6.7bn |
| 2024 | — | $30.4m | $29.6m | $10.9m | $113 | $135 | $6.3bn |
| 2023 | — | $19.0m | $9.2m | $5.5m | $115 | $128 | $6.0bn |
| 2022 | — | $28.2m | −$4.7m | $5.9m | $119 | $122 | $7.0bn |
| 2021 | — | $21.2m | $65.9m | $8.2m | $144 | $125 | $7.7bn |
Insiders and the CEO's stakeSelling
- Chairman & CEO
- Marc N Casper
- Shares held
- 123,200.592
- At that filing's price
- ≈ $76.7m
- Latest Form 4
- Aug 28, 2026
5 insiders sold $66.5m in the last six months and none bought. 92 of 96 sales ran on pre-arranged 10b5-1 plans.
Open-market trades by officers and directors since May 21, 2026.
- SoldMarc N CasperChairman & CEO · 10b5-1 plan$32.8mAug 24, 2026
- SoldMichael D ShaferExecutive Vice President · 10b5-1 plan$15.3mAug 11, 2026
- SoldLisa P. BrittSr. VP and Chief HR Officer$12.4mOct 28, 2026
- SoldGianluca PettitiPresident & COO · 10b5-1 plan$5.7mNov 13, 2026
Leadership and governance on file
All 10 filings
- Oct 30, 2026Leadership change8-K 5.02
- Jan 12, 2026Leadership change8-K 5.02
- Jul 23, 2025Leadership change8-K 5.02
- May 22, 2025Leadership change8-K 5.02
- Feb 19, 2025Leadership change8-K 5.02
- Sep 21, 2023Leadership change8-K/A 5.02
- Jul 13, 2023Leadership change8-K 5.02
- May 26, 2023Leadership change8-K 5.02
- Nov 14, 2022Leadership change8-K 5.02
- Feb 24, 2022Leadership change8-K 5.02
Latest shareholder vote results: May 26, 2026, including the say-on-pay vote.
Where the money went
2021–2025: $17.6bn returned to owners in buybacks and dividends, 52% of net income, and $1.4bn of pay in stock.
Show the figures
| Fiscal year | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $39.2bn | $44.9bn | $42.9bn | $42.9bn | $44.6bn |
| Net income | $7.7bn | $7.0bn | $6.0bn | $6.3bn | $6.7bn |
| Stock-based pay | $230.0m | $307.0m | $278.0m | $301.0m | $310.0m |
| Buybacks | $2.0bn | $3.0bn | $3.0bn | $4.0bn | $3.0bn |
| Dividends | $395.0m | $455.0m | $523.0m | $583.0m | $636.0m |
| Diluted shares | 397m | 394m | 388m | 383m | 378m |
Educational only, not investment advice. Figures are as filed with the SEC: pay from the proxy's pay-versus-performance table, capital allocation from 10-K XBRL data, insider trades from Form 4s over the last six months, events from the last 5 years of filings. The peer group is the one the company chose. See the method.